Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19

NCT05629897 is registered in ClinicalTrials.gov with Fundacin Biomedica Galicia Sur as lead sponsor.

NCT NCT05629897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05629897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19
Lead sponsor
Fundacin Biomedica Galicia Sur
Phase
Not applicable
Overall status
Unknown status
Start date
December 14, 2022
Completion date
November 30, 2023
Enrollment
88 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, neuro-degenerative disease, psychological, sars cov 2 infection